Page last updated: 2024-10-31

midazolam and Myoglobinuria

midazolam has been researched along with Myoglobinuria in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Myoglobinuria: The presence of MYOGLOBIN in URINE usually as a result of rhabdomyolysis.

Research Excerpts

ExcerptRelevanceReference
"Life-threatening myoclonus developed in a patient following inadvertent intrathecal usage of 60% diatrizoate meglumine."1.29Spinal myoclonus following intrathecal administration of diatrizoate meglumine. ( Gutmann, L; Sam, MC, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sam, MC1
Gutmann, L1

Other Studies

1 other study available for midazolam and Myoglobinuria

ArticleYear
Spinal myoclonus following intrathecal administration of diatrizoate meglumine.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 1996, Volume: 6, Issue:4

    Topics: Aged; Contrast Media; Diatrizoate Meglumine; Humans; Hypnotics and Sedatives; Injections, Spinal; Ma

1996